Alert: Rating Downgrade (12/15/23)-GSK plc (NYSE: GSK).


Stock Rating Downgrade

Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for GSK plc (NYSE: GSK) weakened during the last several trading days. GSK’s current Value Trend Rating is D and the prior Rating was C. Details supporting this lower rating are included in our next report.


Recent Price Action

GSK plc (NYSE: GSK) stock closed at $35.88 on 12/15/23 after a decline of -3.0%. Moreover, this decline was accompanied by unusually high trading volume at 173% of normal. The stock is unchanged during the last week but has been strong relative to the market over the last nine months.

Current PriceTarget Research Rating

With future capital returns forecasted to be above the cost of capital, GSK is expected to continue to be a major Value Builder.

GSK plc has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. GSK plc has a very low Appreciation Score of 14 but a neutral Power Rating of 55, triggering the Negative Value Trend Rating.

Be the first to comment

Leave a Reply

Your email address will not be published.